Branched peptides for the modulation of protein-protein interactions: More arms are better than one?

Current Medicinal Chemistry

Volumn 18, Issue 16, 2011, Pages 2429-2437

  Ruvo, M ^a   Sandomenico, A ^a   Tudisco, L ^a   De Falco, S ^a  

^a CNR   (Italy)

Author keywords

Combinatorial peptide library; Cripto; Fc receptor; Hepatitis B virus; Immunoglobulin purification; Interleukin 6; MAP (Mulptiple Antigen Peptide); Multimeric peptides; Neurotensin; PAM (Protein A Mimetic); Squamous Cell Carcinoma Antigen 1; TNF ; VEGFR 1

Indexed keywords

CRIPTO; FC RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 6; NEUROTENSIN; PEPTIDE LIBRARY; PROTEIN A; PROTEIN A MIMETIC PEPTIDE; TRIPEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANGIOGENESIS; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL FATE; EMBRYONIC STEM CELL; HEPATITIS B VIRUS; NONHUMAN; PROTEIN MULTIMERIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; COMBINATORIAL CHEMISTRY TECHNIQUES; HUMANS; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PEPTIDE LIBRARY; PROTEIN BINDING;

EID: 79957946154     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711795843191     Document Type: Article

References (66)

1. Schnur, D.M.; Beno, B.R.; Tebben, A.J.; Cavallaro, C. Methods for combinatorial and parallel library design. Methods. Mol. Biol., 2010, 672, 387-434.
2. Timmerman, P.; Barderas, R.; Desmet, J.; Altschuh, D.; Shochat, S.; Hollestelle, M.J.; Hoppener, J.W.; Monasterio, A.; Casal, J.I.; Meloen, R.H. A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity. J. Biol. Chem., 2009, 284(49), 34126-34134.
3. Merrifield, R.B. Solid Phase Peptide Synthesis I. The synthesis of a tetrapeptide. J. Am. Chem. Soc., 1963, 85, 2149-2154.
4. Geysen, H.M.; Barteling, S.J.; Meloen, R.H. Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc. Natl. Acad. Sci. U. S. A., 1985, 82(1), 178-182. (Pubitemid 15168238)
5. Houghten, R.A. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. U. S. A., 1985, 82(15), 5131-5135. (Pubitemid 16242814)
6. Edwards, P.J. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules. Curr. Opin. Drug. Discov. Devel., 2009, 12(6), 899-914.
7. Shin, D.S.; Kim, D.H.; Chung, W.J.; Lee, Y.S. Combinatorial solid phase peptide synthesis and bioassays. J. Biochem. Mol. Biol., 2005, 38(5), 517-525.
8. Bracci, L.; Falciani, C.; Lelli, B.; Lozzi, L.; Runci, Y.; Pini, A.; De Montis, M.G.; Tagliamonte, A.; Neri, P. Synthetic peptides in the form of dendrimers become resistant to protease activity. J. Biol. Chem., 2003, 278(47), 46590-46595. (Pubitemid 37452233)
9. Verdoliva, A.; Marasco, D.; De Capua, A.; Saporito, A.; Bellofiore, P.; Manfredi, V.; Fattorusso, R.; Pedone, C.; Ruvo, M. A new ligand for immunoglobulin g subdomains by screening of a synthetic peptide library. Chembiochem, 2005, 6(7), 1242-1253. (Pubitemid 40978186)
10. Ruvo, M.; Scardino, P.; Cassani, G.; Fassina, G. Facile Manual Synthesis of Peptide Libraries. Peptide & Protein Letters, 1994, 1, 187-192.
11. Tam, J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. U. S. A., 1988, 85(15), 5409-5413.
12. Francis, M.J.; Hastings, G.Z.; Brown, F.; McDermed, J.; Lu, Y.A.; Tam, J.P. Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus. Immunology, 1991, 73(3), 249-254.
13. Defoort, J.P.; Nardelli, B.; Huang, W.; Tam, J.P. A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity. Int. J. Pept. Protein Res., 1992, 40(3-4), 214-221.
14. Fassina, G. Oriented immobilization of peptide ligands on solid supports. J. Chromatogr., 1992, 591(1-2), 99-106.
15. Fassina, G.; Corti, A.; Cassani, G. Affinity enhancement of complementary peptide recognition. Int. J. Pept. Protein Res., 1992, 39(6), 549-556.
16. Bracci, L.; Lozzi, L.; Pini, A.; Lelli, B.; Falciani, C.; Niccolai, N.; Bernini, A.; Spreafico, A.; Soldani, P.; Neri, P. A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin. Biochemistry, 2002, 41(32), 10194-10199. (Pubitemid 34856443)
17. Ruvo, M.; Fassina, G. End-group modified retro-inverso isomers of tripeptide oxytocin analogues: binding to neurophysin II and enhancement of its self-association properties. Int. J. Pept. Protein. Res., 1995, 45(4), 356-365.
18. Fassina, G.; Cassani, G.; Corti, A. Binding of human tumor necrosis factor alpha to multimeric complementary peptides. Arch. Biochem. Biophys., 1992, 296(1), 137-143.
19. Palombo, G.; Dani, M.; Fassina, G. Selection of Peptide Ligands for a-1 Antitrypsin from a Phage Display Library. Protein. Pept. Lett., 1999, 6(1), 43-48. (Pubitemid 129623524)
20. Radulescu, R.T.; Bellitti, M.R.; Ruvo, M.; Cassani, G.; Fassina, G. Binding of the LXCXE insulin motif to a hexapeptide derived from retinoblastoma protein. Biochem. Biophys. Res. Commun., 1995, 206(1), 97-102.
21. Marino, M.; Ruvo, M.; De Falco, S.; Fassina, G. Prevention of systemic lupus erythematosus in MRL/lpr mice by administration of an immunoglobulin- binding peptide. Nat. Biotechnol., 2000, 18(7), 735-739. (Pubitemid 30460688)
22. Ponticelli, S.; Marasco, D.; Tarallo, V.; Albuquerque, R.J.; Mitola, S.; Takeda, A.; Stassen, J.M.; Presta, M.; Ambati, J.; Ruvo, M.; De Falco, S. Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1. J. Biol. Chem., 2008, 283(49), 34250-34259.
23. Lonardo, E.; Parish, C.L.; Ponticelli, S.; Marasco, D.; Ribeiro, D.; Ruvo, M.; De Falco, S.; Arenas, E.; Minchiotti, G. A small synthetic cripto blocking Peptide improves neural induction, dopaminergic differentiation, and functional integration of mouse embryonic stem cells in a rat model of Parkinson's disease. Stem Cells, 2010, 28(8), 1326-1337.
24. De Falco, S.; Ruvo, M.; Verdoliva, A.; Scarallo, A.; Raimondo, D.; Raucci, A.; Fassina, G. N-terminal myristylation of HBV preS1 domain enhances receptor recognition. J. Pept. Res., 2001, 57(5), 390-400. (Pubitemid 32769044)
25. Falciani, C.; Lelli, B.; Brunetti, J.; Pileri, S.; Cappelli, A.; Pini, A.; Pagliuca, C.; Ravenni, N.; Bencini, L.; Menichetti, S.; Moretti, R.; De Prizio, M.; Scatizzi, M.; Bracci, L. Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept. Curr. Cancer Drug Targets, 2010. Epub Jun26.
26. Pini, A.; Falciani, C.; Mantengoli, E.; Bindi, S.; Brunetti, J.; Iozzi, S.; Rossolini, G.M.; Bracci, L. A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. FASEB J., 2010, 24(4), 1015-1022.
27. Fassina, G.; Verdoliva, A.; Odierna, M.R.; Ruvo, M.; Cassani, G. Protein A mimetic peptide ligand for affinity purification of antibodies. J. Mol. Recognit., 1996, 9(5-6), 564-569. (Pubitemid 126447010)
28. Kofoed, J.; Darbre, T.; Reymond, J.L. Artificial aldolases from peptide dendrimer combinatorial libraries. Org. Biomol. Chem., 2006, 4(17), 3268-3281. (Pubitemid 44289454)
29. Maillard, N.; Clouet, A.; Darbre, T.; Reymond, J.L. Combinatorial libraries of peptide dendrimers: design, synthesis, on-bead high-throughput screening, bead decoding and characterization. Nat. Protoc., 2009, 4(2), 132-142.
30. Crespo, L.; Sanclimens, G.; Montaner, B.; Perez-Tomas, R.; Royo, M.; Pons, M.; Albericio, F.; Giralt, E. Peptide dendrimers based on polyproline helices. J. Am. Chem. Soc., 2002, 124(30), 8876-8883. (Pubitemid 34809633)
31. Sanclimens, G.; Crespo, L.; Giralt, E.; Albericio, F.; Royo, M. Preparation of de novo globular proteins based on proline dendrimers. J. Org. Chem., 2005, 70(16), 6274-6281. (Pubitemid 41076510)
32. Sanclimens, G.; Shen, H.; Giralt, E.; Albericio, F.; Saltzman, M.W.; Royo, M. Synthesis and screening of a small library of proline-based biodendrimers for use as delivery agents. Biopolymers, 2005, 80(6), 800-814. (Pubitemid 43266586)
33. Wallace, A.; Altamura, S.; Toniatti, C.; Vitelli, A.; Bianchi, E.; Delmastro, P.; Ciliberto, G.; Pessi, A. A Multimeric Synthetic Peptide Combinatorial Library. Pept. Res., 1994, 7(1), 27-31. (Pubitemid 2058393)
34. Pinilla, C.; Appel, J.R.; Blanc, P.; Houghten, R.A. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. Biotechniques, 1992, 13(6), 901-905.
35. Imai, K.; Takaoka, A. Comparing antibody and small-molecule therapies for cancer. Nat. Rev. Cancer, 2006, 6(9), 714-727. (Pubitemid 44286003)
36. Brennan, D.J.; O'Connor, D.P.; Rexhepaj, E.; Ponten, F.; Gallagher, W.M. Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat. Rev. Cancer, 2010, 10(9), 605-617.
37. Olafsen, T.; Wu, A.M. Antibody vectors for imaging. Semin. Nucl. Med., 2010, 40(3), 167-181.
38. Fassina, G.; Verdoliva, A.; Palombo, G.; Ruvo, M.; Cassani, G. Immunoglobulin specificity of TG19318: a novel synthetic ligand for antibody affinity purification. J. Mol. Recognit., 1998, 11(1-6), 128-133. (Pubitemid 29105286)
39. Bak, H.; Thomas, O.R. Evaluation of commercial chromatographic adsorbents for the direct capture of polyclonal rabbit antibodies from clarified antiserum. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci, 2007, 848(1), 116-130. (Pubitemid 46367762)
40. Palombo, G.; De Falco, S.; Tortora, M.; Cassani, G.; Fassina, G. A synthetic ligand for IgA affinity purification. J. Mol. Recognit., 1998, 11(1-6), 243-246. (Pubitemid 29105309)
41. Palombo, G.; Rossi, M.; Cassani, G.; Fassina, G. Affinity purification of mouse monoclonal IgE using a protein A mimetic ligand (TG19318) immobilized on solid supports. J. Mol. Recognit., 1998, 11(1-6), 247-249. (Pubitemid 29105310)
42. Palombo, G.; Verdoliva, A.; Fassina, G. Affinity purification of immunoglobulin M using a novel synthetic ligand. J. Chromatogr. B Biomed. Sci. Appl., 1998, 715(1), 137-145. (Pubitemid 28403606)
43. Furka, A.; Sebestyen, F.; Asgedom, M.; Dibo, G. General method for rapid synthesis of multicomponent peptide mixtures. Int. J. Pept. Protein Res., 1991, 37(6), 487-493.
44. Mannik, M. Pathophysiology of circulating immune complexes. Arthritis Rheum., 1982, 25(7), 783-787. (Pubitemid 12022148)
45. Theofilopoulos, A.N.; Dixon, F.J. Etiopathogenesis of murine SLE. Immunol. Rev., 1981, 55, 179-216. (Pubitemid 11157606)
46. Fassina, G.; Verdoliva, A.; Ruvo, M. Peptide ligands for the constant region of immunoglobulins. Patent EP 0752425, January 8, 1997.
47. Ferrara, N.; Gerber, H.P.; LeCouter, J. The biology of VEGF and its receptors. Nat. Med., 2003, 9(6), 669-676. (Pubitemid 36749215)
48. Carmeliet, P. Angiogenesis in life, disease and medicine. Nature, 2005, 438(7070), 932-936. (Pubitemid 43093958)
49. De Falco, S.; Gigante, B.; Persico, M.G. Structure and function of placental growth factor. Trends Cardiovasc. Med., 2002, 12(6), 241-246. (Pubitemid 35286760)
50. Fischer, C.; Mazzone, M.; Jonckx, B.; Carmeliet, P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat. Rev. Cancer, 2008, 8(12), 942-956.
51. Ponticelli, S.; Braca, A.; De Tommasi, N.; De Falco, S. Competitive ELISAbased screening of plant derivatives for the inhibition of VEGF family members interaction with vascular endothelial growth factor receptor 1. Planta Med., 2008, 74(4), 401-406. (Pubitemid 351578797)
52. Ambati, B.K.; Nozaki, M.; Singh, N.; Takeda, A.; Jani, P.D.; Suthar, T.; Albuquerque, R.J.; Richter, E.; Sakurai, E.; Newcomb, M.T.; Kleinman, M.E.; Caldwell, R.B.; Lin, Q.; Ogura, Y.; Orecchia, A.; Samuelson, D.A.; Agnew, D.W.; St Leger, J.; Green, W.R.; Mahasreshti, P.J.; Curiel, D.T.; Kwan, D.; Marsh, H.; Ikeda, S.; Leiper, L.J.; Collinson, J.M.; Bogdanovich, S.; Khurana, T.S.; Shibuya, M.; Baldwin, M.E.; Ferrara, N.; Gerber, H.P.; De Falco, S.; Witta, J.; Baffi, J.Z.; Raisler, B.J.; Ambati, J. Corneal avascularity is due to soluble VEGF receptor-1. Nature, 2006, 443(7114), 993-997. (Pubitemid 44646176)
53. Li, J.Y.; Christophersen, N.S.; Hall, V.; Soulet, D.; Brundin, P. Critical issues of clinical human embryonic stem cell therapy for brain repair. Trends Neurosci., 2008, 31(3), 146-153.
54. Lindvall, O.; Kokaia, Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol. Sci., 2009, 30(5), 260-267.
55. Strizzi, L.; Bianco, C.; Normanno, N.; Salomon, D. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene, 2005, 24(37), 5731-5741. (Pubitemid 43086133)
56. Minchiotti, G. Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology. Oncogene, 2005, 24(37), 5668-5675. (Pubitemid 43086127)
57. Boheler, K.R.; Crider, D.G.; Tarasova, Y.; Maltsev, V.A. Cardiomyocytes derived from embryonic stem cells. Methods Mol. Med., 2005, 108, 417-435.
58. Lindvall, O.; Hagell, P. Clinical observations after neural transplantation in Parkinson's disease. Prog. Brain Res., 2000, 127, 299-320. (Pubitemid 35461264)
59. Winkler, C.; Kirik, D.; Bjorklund, A. Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci., 2005, 28(2), 86-92. (Pubitemid 40178925)
60. Parish, C.L.; Parisi, S.; Persico, M.G.; Arenas, E.; Minchiotti, G. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease. Stem Cells, 2005, 23(4), 471-476. (Pubitemid 40478485)
61. Shepard, C.W.; Simard, E.P.; Finelli, L.; Fiore, A.E.; Bell, B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev., 2006, 28, 112-125. (Pubitemid 44289094)
62. Petersen, J.; Dandri, M.; Mier, W.; Lutgehetmann, M.; Volz, T.; von Weizsacker, F.; Haberkorn, U.; Fischer, L.; Pollok, J.M.; Erbes, B.; Seitz, S.; Urban, S. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat. Biotechnol., 2008, 26(3), 335-341. (Pubitemid 351355128)
63. De Falco, S.; Ruvoletto, M.G.; Verdoliva, A.; Ruvo, M.; Raucci, A.; Marino, M.; Senatore, S.; Cassani, G.; Alberti, A.; Pontisso, P.; Fassina, G. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J. Biol. Chem., 2001, 276(39), 36613-36623.
64. Pontisso, P.; Calabrese, F.; Benvegnu, L.; Lise, M.; Belluco, C.; Ruvoletto, M.G.; Marino, M.; Valente, M.; Nitti, D.; Gatta, A.; Fassina, G. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br. J. Cancer, 2004, 90(4), 833-837. (Pubitemid 38406594)
65. Falciani, C.; Fabbrini, M.; Pini, A.; Lozzi, L.; Lelli, B.; Pileri, S.; Brunetti, J.; Bindi, S.; Scali, S.; Bracci, L. Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting. Mol. Cancer Ther., 2007, 6(9), 2441-2448. (Pubitemid 47480409)
66. Falciani, C.; Brunetti, J.; Pagliuca, C.; Menichetti, S.; Vitellozzi, L.; Lelli, B.; Pini, A.; Bracci, L. Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents. Chem. Med. Chem., 2010, 5(4), 567-574.